rs4068622

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001388367.1(NBPF9):​c.-169A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 23)
Exomes 𝑓: 0.0000011 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

NBPF9
NM_001388367.1 5_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.735

Publications

1 publications found
Variant links:
Genes affected
NBPF9 (HGNC:31991): (NBPF member 9) This gene is a member of the neuroblastoma breakpoint family (NBPF) which consists of dozens of recently duplicated genes primarily located in segmental duplications on human chromosome 1. This gene family has experienced its greatest expansion within the human lineage and has expanded, to a lesser extent, among primates in general. Members of this gene family are characterized by tandemly repeated copies of DUF1220 protein domains. Gene copy number variations in the human chromosomal region 1q21.1, where most DUF1220 domains are located, have been implicated in a number of developmental and neurogenetic diseases such as microcephaly, macrocephaly, autism, schizophrenia, cognitive disability, congenital heart disease, neuroblastoma, and congenital kidney and urinary tract anomalies. Altered expression of some gene family members is associated with several types of cancer. This gene family contains numerous pseudogenes. [provided by RefSeq, Apr 2013]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.04).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NBPF9NM_001388367.1 linkc.-169A>G 5_prime_UTR_variant Exon 6 of 30 ENST00000698832.1 NP_001375296.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NBPF9ENST00000698832.1 linkc.-169A>G 5_prime_UTR_variant Exon 6 of 30 NM_001388367.1 ENSP00000513968.1 P0DPF3-1

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00000107
AC:
1
AN:
931010
Hom.:
0
Cov.:
13
AF XY:
0.00000211
AC XY:
1
AN XY:
474096
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
19840
American (AMR)
AF:
0.00
AC:
0
AN:
26692
Ashkenazi Jewish (ASJ)
AF:
0.0000490
AC:
1
AN:
20414
East Asian (EAS)
AF:
0.00
AC:
0
AN:
31852
South Asian (SAS)
AF:
0.00
AC:
0
AN:
62094
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
32812
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3072
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
692460
Other (OTH)
AF:
0.00
AC:
0
AN:
41774
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
23

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.91
DANN
Benign
0.17
PhyloP100
-0.73
PromoterAI
0.0028
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4067685; hg19: chr1-148347023; API